Regeneron Pharmaceuticals, Inc.(NASDAQ : REGN)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Biotechnology
|SNSS||Sunesis Pharmaceuticals, Inc.||3.80%||10.92||0.7%||$763.35m|
|VRTX||Vertex Pharmaceuticals, Inc.||-1.61%||198.34||1.9%||$408.06m|
|GILD||Gilead Sciences, Inc.||0.00%||68.29||1.0%||$401.30m|
|REGN||Regeneron Pharmaceuticals, Inc.||0.44%||577.16||2.7%||$355.46m|
|NTLA||Intellia Therapeutics, Inc.||-2.21%||138.72||2.3%||$258.07m|
|CRSP||CRISPR Therapeutics AG||1.82%||123.22||0.6%||$147.36m|
|EXAS||EXACT Sciences Corp.||1.83%||109.81||18.1%||$125.85m|
|XBIO||Xenetic Biosciences, Inc.||16.22%||4.73||0.0%||$118.75m|
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically-humanized mice to produce optimized fully-human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY.